IceCure Medical (ICCM) Income from Continuing Operations (2020 - 2026)
IceCure Medical's (ICCM) quarterly Income from Continuing Operations came in at 4247000.0 in Q1 2026, up 18.37% year-on-year from 3588000.0 in Q1 2025, and little changed on a QoQ basis from 4243000.0 in Q4 2025.
IceCure Medical (ICCM) Income from Continuing Operations (2020 - 2026) Analysis & Trends
IceCure Medical (ICCM) has 7 years of Income from Continuing Operations data on file, last reported at 4247000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 18.37% year-over-year to 4247000.0 in Q1 2026; TTM through Mar 2026 was 15713000.0, a 284.21% increase from a year earlier, with the FY2025 full-year figure at 11886000.0, up 49.84% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 4247000.0, roughly flat from 4243000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for ICCM reached as high as 4425000.0 in Q1 2022 and fell as low as 46910000.0 in Q4 2023.
- Historically, Income from Continuing Operations has averaged 3419352.94 across 5 years, with a median of 3957000.0 in 2023.
- On a YoY basis, Income from Continuing Operations climbed as much as 270.91% in 2022 and fell as far as 53.49% in 2022.
- Year by year, Income from Continuing Operations stood at 46856000.0 in 2022, then declined by 0.12% to 46910000.0 in 2023, then jumped by 58.76% to 19348000.0 in 2024, then soared by 121.93% to 4243000.0 in 2025, then rose by 0.09% to 4247000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 4247000.0 in Q1 2026, 4243000.0 in Q4 2025, and 3859000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | IceCure Medical | 7.92 Mn | -193,612.29 | 295,000.00 | 4.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.25 Mn |
| Dec 31, 2025 | 4.24 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.36 Mn |
| Mar 31, 2025 | 3.59 Mn |
| Dec 31, 2024 | -19.35 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.61 Mn |
| Dec 31, 2023 | -46.91 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 4.08 Mn |
| Mar 31, 2023 | 3.96 Mn |
| Dec 31, 2022 | -46.86 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | 4.28 Mn |
| Mar 31, 2022 | 4.43 Mn |
| Dec 31, 2021 | -30.53 Mn |
| Sep 30, 2021 | 2.85 Mn |
| Jun 30, 2021 | 2.55 Mn |